Raphael J. Landovitz, M.D., M.Sc.
Co-Director, Combination Prevention Core
|Address||Center for Clinical AIDS Research & Education
David Geffen School of Medicine at UCLA
9911 W. Pico Blvd, Suite 980
Los Angeles, CA 90035
Dr. Landovitz graduated from Princeton University in 1992 and received his M.D. from Harvard Medical School in 2996. He trained at Brigham and Women’s Hospital in Boston, Massachusetts in Internal Medicine, and completed subspecialty training in Infectious Diseases and HIV at the Brigham and Women’s Hospital and Massachusetts General Hospital. Dr. Landovitz additionally served as Chief Resident at Brigham and Women’s Hospital, and stayed on staff in the Division of Infectious Diseases as an Infectious Disease and HIV care provider and clinical researcher. He also served as Medical Co-Director of the Vietnam-CDC-Harvard Medical School-AIDS-Partnership (VCHAP), helping to train Vietnamese physicians in HIV care and treatment. Dr. Landovitz relocated to Los Angeles in 2006, and is Currently Assistant Professor of Infectious Diseases at UCLA. He has led combination prevention intervention studies and projects using Post-exposure (PEP) and Pre-exposure (PrEP) strategies for MSM, as well as being part of the DAIDS-funded AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN). He was awarded the John Carey Young Investigator Award by the ACTG in 2010.
M.Sc., Clinical Research, University of California, Los Angeles, CA, US
Fellowship, Infectious Disease/HIV, Massachusetts General Hospital / Brigham and Women’s Hospital, Boston, MA, US
Residency, Internal Medicine, Brigham and Women’s Hospital, Boston, MA, US
M.D., Medicine, Harvard University, Boston, MA, US
B.A., Chemistry, Princeton University, Princeton, NJ, US
Research and Interests:
HIV/AIDS, biomedical interventions, infectious diseases